IN USE PRODUCT SAFETY ASSESSMENT REPORT FOR TRUXIMA®▼ AND RIXATHON®▼ (RITUXIMAB BIOSIMILARs)

· London and South East Regional Medicines Information

This review discusses practical safety considerations associated with the introduction of the two biosimilar rituximab products.

 

CancersHaematological disordersMedicines SafetyMusculo-skeletal disordersNewsRituximab

Attachments